Political poisoning with dioxins - A weapon of chemical "disgracefulness"

Harefuah

Volumn 144, Issue 10, 2005, Pages 729-735

  Finkelstein, Arseny ^a   Rotman, Eran ^a   Eisenkraft, Arik ^a   Krivoy, Amir ^a   Laish, Ido ^a   Tashma, Zeev ^a   Hoffman, Azik ^a   Yehezkelli, Yoav ^a  

^a MEDICAL CORPS   (Israel)

Author keywords

Cancer; Chemical terrorism; Chloracne; Dioxins; Poisoning; TCDD

Indexed keywords

CHEMICAL WARFARE AGENT; DIOXIN;

INTOXICATION; REVIEW;

ANIMALS; ANTIDOTES; CARCINOGENS; DIOXINS; HUMANS; TETRACHLORODIBENZODIOXIN;

EID: 28444475865     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Geyer HJ, Schramm KW, Feicht EA & al, Half-lives of tetra-, penta-, hexa-, hepta-, and octachlorodibenzo-p-dioxin in rats, monkeys, and humans - a critical review. Chemosphere, 2002; 48: 631-44.
2. Schecter A, Cramer P, Boggess K & al, Intake of dioxins and related compounds from food in the U.S. population. J Toxicol Environ Health A, 2001; 63: 1-18.
3. Aylward LL & Hays SM, Temporal trends in human TCDD body burden: decreases over three decades and implications for exposure levels. J Expo Anal Environ Epidemiol, 2002; 12: 319-28.
4. Geusau A, Abraham K, Geissler K & al, Severe 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) intoxication: clinical and laboratory effects. Environ Health Perspect, 2001; 109: 865-9.
5. Orme S & Kegley S, PAN Pesticide Database, Pesticide Action Network, North America, http: //www.pesticideinfo.org. San Francisco, CA. 2004.
6. Greene JF, Hays S & Paustenbach D, Basis for a proposed reference dose (RfD) for dioxin of 1-10 pg/kg-day: a weight of evidence evaluation of the human and animal studies. J Toxicol Environ Health B Crit Rev, 2003; 6: 115-59.
7. USEPA, Exposure and human health reassessment of 2,3,7,8- tetrachlorodibenzo-p-dioxin and related Compounds. Draft Final. National Center of Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC. 2000.
8. Vrzal R, Ulrichova J & Dvorak Z, Aromatic hydrocarbon receptor status in the metabolism of xenobiotics under normal and pathophysiological conditions. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2004; 148: 3-10.
9. Kahn PC, Gochfeld M, Nygren M & al, Dioxins and dibenzofurans in blood and adipose tissue of Agent Orange-exposed Vietnam veterans and matched controls. JAMA, 1988; 259: 1661-7.
10. Collins JJ, Strauss ME, Levinskas GJ amp; al, The mortality experience of workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a trichlorophenol process accident. Epidemiology, 1993; 4: 7-13.
11. Commoner B, The political history of dioxin. http: //www.greens.org/s-r/ 078/07-03.html. Second Citizens Conference on Dioxin. 1994.
12. Moses M, Lilis R, Crow KD & al, Health status of workers with past exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the manufacture of 2,4,5-trichlorophenoxyacetic acid: comparison of findings with and without chloracne. Am J Ind Med, 1984; 5: 161-82.
13. Pastor MA, Carrasco L, Izquierdo MJ & al, Chloracne: histopathologic findings in one case. J Cutan Pathol, 2002; 29: 193-9.
14. McGregor DB, Partensky C, Wilbourn J & al, An IARC evaluation of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans as risk factors in human carcinogenesis. Environ Health Perspect, 1998; 106 (Suppl 2): 755-60.
15. Kuratsune M, Ikeda M, Nakamura Y & al, A cohort study on mortality of "yusho" patients: a preliminary report. Princess Takamatsu Symp, 1987; 18: 61-6.
16. Hardell L amp; Eriksson M, Soft-tissue sarcomas, phenoxy herbicides, and chlorinated phenols. Lancet, 1981; 2: 250.
17. Bertazzi PA, Consonni D, Bachetti S & al, Health effects of dioxin exposure: a 20-year mortality study. Am J Epidemiol, 2001; 153: 1031-44.
18. Centers for Disease Control, The association of selected cancers with service in the US military in Vietnam. I. Non-Hodgkin lymphoma. The Selected Cancers Cooperative Study Group. Arch Intern Med, 1990; 150: 2473-2483.
19. Tusscher GW & Koppe JG, Perinatal dioxin exposure and later effects - a review. Chemosphere, 2004; 54: 1329-36.
20. Baccarelli A, Mocarelli P, Patterson DG Jr & al, Immunological effects of dioxin: new results from Seveso and comparison with other studies. Environ Health Perspect, 2002; 110: 1169-73.
21. Courtney KD, Gaylor DW, Hogan MD & al, Teratogenic evaluation of 2,4,5-T. Science, 1970; 168: 864-6.
22. Ryan JJ, Amirova Z & Carrier G, Sex ratios of children of Russian pesticide producers exposed to dioxin. Environ Health Perspect, 2002; 110: A699-701.
23. Steenland K, Piacitelli L, Deddens J & al, Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Natl Cancer Inst, 1999; 91: 86.
24. Pesatori AC, Zocchetti C, Guercilena S & al, Dioxin exposure and non-malignant health effects: a mortality study. Occup Environ Med, 1998; 55: 126-31.
25. Gradin K, McGuire J, Wenger RH & al, Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol Cell Biol, 1996; 16: 5221-31.
26. Geusau A, Tschachler E, Meixner M & al, Olestra increases faecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Lancet, 1999; 54: 1266-7.
27. Iida T, Hirakawa H, Matsueda T & al, Polychlorinated dibenzo-p-dioxins and related compounds: correlations of levels in human tissues and in blood. Chemosphere, 1999; 38: 2767-74.
28. Sterling JB & Hanke CW, Dioxin toxicity and chloracne in the Ukraine. J Drugs Dermatol, 2005; 4: 148-50.
29. Abraham K, Geusau A, Tosun Y & al, Severe 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction. Clin Pharmacol Ther, 2002; 72: 163-74.
30. Webb KB, Ayres SM, Mikes J & al, The diagnosis of dioxin-associated illness. Am J Prev Med, 1986; 2: 103-8.
31. Geusau A, Schmaldienst S, Derfler K & al, Severe 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) intoxication: kinetics and trials to enhance elimination in two patients. Arch Toxicol, 2002; 76: 316-25.
32. Geusau A, Tschachler E, Meixner M & al, Cutaneous elimination of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Br J Dermatol, 2001; 145: 938-43.
33. Sakurai K, Todaka E, Saito Y & al, Pilot study to reduce dioxins in the human body. Intern Med, 2004; 43: 792-5.